https://pharmadog.xyz/news/169732 pharmadog en 2026-07-31T18:22:56.000Z AbbVie says Skyrizi maintains strong sales momentum as competition rises https://pharmadog.xyz/news/169573 pharmadog en 2026-07-31T17:22:21.000Z Pharma groups support revised 340B rebate pilot that permits limited rebate denials https://pharmadog.xyz/news/169489 pharmadog en 2026-07-31T17:02:27.000Z Trump administration revises 340B rebate pilot, sparking hospital backlash https://pharmadog.xyz/news/169337 pharmadog en 2026-07-31T16:36:25.000Z Moderna delays norovirus vaccine readout, cites insufficient infections https://pharmadog.xyz/news/169361 pharmadog en 2026-07-31T16:28:44.000Z Eli Lilly and Resilience commit $750 million to expand U.S. KwikPen device capacity for diabetes and obesity treatments https://pharmadog.xyz/news/169253 pharmadog en 2026-07-31T16:11:00.000Z Novo Nordisk's heart drug ziltivekimab fails Phase 3 trial, raising doubts on inflammation-targeted therapies https://pharmadog.xyz/news/169169 pharmadog en 2026-07-31T15:35:15.000Z Novo Nordisk's late-stage anti-inflammatory heart drug fails Phase 3 trial https://pharmadog.xyz/news/169213 pharmadog en 2026-07-31T15:29:20.000Z AbbVie shares slip 4% as Q2 immunology earnings beat falls short of lofty expectations https://pharmadog.xyz/news/169214 pharmadog en 2026-07-31T15:24:07.000Z Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9% https://pharmadog.xyz/news/169215 pharmadog en 2026-07-31T15:19:14.000Z Moderna maintains 10% growth target despite Phase 3 norovirus miss https://pharmadog.xyz/news/169105 pharmadog en 2026-07-31T15:06:47.000Z Sanofi CEO pledges to rebuild trust and expand partnership with Regeneron https://pharmadog.xyz/news/168958 pharmadog en 2026-07-31T14:59:38.000Z Ratio Therapeutics secures $70M Series C for radiopharma trials as Vogenx eyes $67M IPO https://pharmadog.xyz/news/169002 pharmadog en 2026-07-31T14:47:59.000Z Bexorg names Bruce Car as new chief scientific officer https://pharmadog.xyz/news/168809 pharmadog en 2026-07-31T13:28:17.000Z FDA advisory panel backs experimental Replimune melanoma therapy after two prior rejections https://pharmadog.xyz/news/168641 pharmadog en 2026-07-31T12:56:02.000Z Alnylam cuts TTR franchise guidance, market cap loses $10.8B as shares tumble 28% https://pharmadog.xyz/news/168642 pharmadog en 2026-07-31T12:39:03.000Z UniQure prepares for FDA advisory committee on Huntington’s gene therapy amid rare-disease regulatory jitters https://pharmadog.xyz/news/168661 pharmadog en 2026-07-31T12:32:46.000Z Novo Nordisk's anti-inflammatory drug ziltivekimab fails to cut major heart events in Phase 3 trial https://pharmadog.xyz/news/168524 pharmadog en 2026-07-31T12:28:22.000Z Senate advances Erica Schwartz’s CDC director nomination to full Senate vote https://pharmadog.xyz/news/168193 pharmadog en 2026-07-31T11:00:06.000Z Ionis veteran scientist Frank Bennett to retire in 2027 as Recursion appoints its first AI chief https://pharmadog.xyz/news/168194 pharmadog en 2026-07-31T10:42:02.000Z Karyopharm stock tumbles after Phase 3 Xpovio trial fails in endometrial cancer https://pharmadog.xyz/news/168720 pharmadog en 2026-07-31T08:59:00.000Z Novo Nordisk's ziltivekimab fails phase 3 trial, jeopardizing CKD program https://pharmadog.xyz/news/167815 pharmadog en 2026-07-31T08:30:00.000Z Authors rebut mischaracterization of their 2023 Lancet Covid study in recent op-ed https://pharmadog.xyz/news/167816 pharmadog en 2026-07-31T08:30:00.000Z Syphilis cases rise among unhoused drug users at San Diego-Tijuana border as researchers face NIH limits and penicillin shortage https://pharmadog.xyz/news/167814 pharmadog en 2026-07-31T08:30:00.000Z Opinion: Limb girdle muscular dystrophy patients face a maddening reality https://pharmadog.xyz/news/167813 pharmadog en 2026-07-31T08:30:00.000Z ADA’s reputation erodes after controversial physician expulsions at annual meeting https://pharmadog.xyz/news/167444 pharmadog en 2026-07-31T07:24:14.000Z Latigo Biotherapeutics reports non-opioid drug cuts acute pain in Phase 2b trial https://pharmadog.xyz/news/167445 pharmadog en 2026-07-31T07:18:16.000Z Apnimed secures $192 million IPO to fund sleep-apnea drug program targeting 2027 launch https://pharmadog.xyz/news/167872 pharmadog en 2026-07-31T04:10:00.000Z Apnimed upsizes IPO to $192 million to fund launch of oral sleep‑apnea drug https://pharmadog.xyz/news/165781 pharmadog en 2026-07-30T22:29:40.000Z FDA advisory panel backs Replimune’s melanoma immunotherapy combined with Opdivo https://pharmadog.xyz/news/165614 pharmadog en 2026-07-30T21:25:00.000Z FDA advisory panel backs Replimune's melanoma therapy RP1, raising approval prospects https://pharmadog.xyz/news/165289 pharmadog en 2026-07-30T20:12:00.000Z Alnylam shares tumble nearly 30% after cutting revenue outlook for key amyloidosis drugs https://pharmadog.xyz/news/164909 pharmadog en 2026-07-30T19:22:42.000Z Regeneron and Sanofi explore expanded partnership for Dupixent follow-on candidates https://pharmadog.xyz/news/164910 pharmadog en 2026-07-30T19:11:21.000Z Replimune argues its oncolytic virus plus checkpoint inhibitor benefits advanced melanoma patients at FDA advisory meeting https://pharmadog.xyz/news/164845 pharmadog en 2026-07-30T19:03:12.000Z Podcast debates FDA’s handling of Duchenne drugs and upcoming executive changes https://pharmadog.xyz/news/165732 pharmadog en 2026-07-30T18:13:00.000Z Replimune's melanoma virus therapy wins FDA advisory committee vote after two rejections https://pharmadog.xyz/news/164505 pharmadog en 2026-07-30T17:37:01.000Z Trump administration delays start of first pharma tariff wave originally set for July 31 https://pharmadog.xyz/news/168455 pharmadog en 2026-07-30T16:26:00.000Z Legend Biotech CEO Ying Huang resigns abruptly, board taps interim leader https://pharmadog.xyz/news/164214 pharmadog en 2026-07-30T16:03:00.000Z FTC Sues Hims & Hers for Alleged Illegal Sharing of Patient Data and Deceptive Billing https://pharmadog.xyz/news/164081 pharmadog en 2026-07-30T15:58:35.000Z Trump's CDC nominee Erica Schwartz clears key Senate committee vote https://pharmadog.xyz/news/164215 pharmadog en 2026-07-30T15:52:00.000Z Johnson & Johnson secures option to acquire in-vivo CAR-T developer Sail Biomedicines for up to $2.6 billion https://pharmadog.xyz/news/164174 pharmadog en 2026-07-30T15:32:44.000Z BMS beats Q2 forecasts and lifts 2026 outlook despite delays in Cobenfy and milvexian data https://pharmadog.xyz/news/164175 pharmadog en 2026-07-30T15:29:13.000Z Regeneron defends M&A stance as cash hoard reaches $18 billion amid trial setbacks https://pharmadog.xyz/news/164082 pharmadog en 2026-07-30T15:24:12.000Z UCB shares dip as investors worry forecast may be too optimistic despite Bimzelx sales beat https://pharmadog.xyz/news/164083 pharmadog en 2026-07-30T15:18:33.000Z Sanofi CEO Garijo outlines R&D overhaul, M&A push and China focus to counter patent cliff https://pharmadog.xyz/news/164084 pharmadog en 2026-07-30T15:16:51.000Z Pfizer reports Phase 3 success for Litfulo in vitiligo trials; Braveheart and Attovia target $275M and $182M IPOs https://pharmadog.xyz/news/164085 pharmadog en 2026-07-30T15:10:46.000Z AtaiBeckley secured co-development and royalty offers before $2.8 B Lilly acquisition https://pharmadog.xyz/news/163953 pharmadog en 2026-07-30T15:02:43.000Z Takeda, Regeneron, Sanofi and Bristol Myers Squibb announce pipeline cuts in quarterly updates https://pharmadog.xyz/news/163954 pharmadog en 2026-07-30T14:22:50.000Z Included Health to acquire Firefly Health, signaling push into alternative health plans https://pharmadog.xyz/news/163830 pharmadog en 2026-07-30T14:17:10.000Z Senate health panel confirms Trump picks for CDC director and pandemic preparedness chief https://pharmadog.xyz/news/163786 pharmadog en 2026-07-30T14:16:49.000Z Ipsen says €2 billion cash reserves give it firepower for more M&A https://pharmadog.xyz/news/163908 pharmadog en 2026-07-30T13:55:00.000Z Leo International Precision Health AG discloses insider share acquisition by board member Leo Wang https://pharmadog.xyz/news/163909 pharmadog en 2026-07-30T13:55:00.000Z Leo International Precision Health AG board member Leo Wang buys shares worth €55,933 https://pharmadog.xyz/news/163721 pharmadog en 2026-07-30T13:45:55.000Z Federal judge rejects 26 states' bid to delay Medicaid work requirement rollout https://pharmadog.xyz/news/163657 pharmadog en 2026-07-30T13:30:04.000Z Gerresheimer sells Centor and Primary Packaging Plastics units to Apax Partners for €1.5 billion https://pharmadog.xyz/news/163658 pharmadog en 2026-07-30T13:25:38.000Z Alnylam lowers Amvuttra sales outlook amid waning demand, shares slide https://pharmadog.xyz/news/163722 pharmadog en 2026-07-30T13:22:30.000Z Rising oil prices could lift manufacturing costs of an HIV drug, Unitaid report says https://pharmadog.xyz/news/163701 pharmadog en 2026-07-30T13:20:37.000Z Analysts say Daiichi Sankyo’s ADC pipeline lags rivals as cash flow peaks, cutting expectations https://pharmadog.xyz/news/163573 pharmadog en 2026-07-30T13:08:40.000Z FDA panel rejects Capricor's Duchenne drug, citing insufficient efficacy data https://pharmadog.xyz/news/163385 pharmadog en 2026-07-30T11:51:15.000Z J&J strikes up to $925M deal with Sail Biomedicines, secures option to buy for $2.58B https://pharmadog.xyz/news/163277 pharmadog en 2026-07-30T11:49:48.000Z Ebola cases approach key milestone as vaccine candidates draw near completion https://pharmadog.xyz/news/163257 pharmadog en 2026-07-30T11:44:28.000Z Sanofi CEO pledges deeper review of late-stage pipeline before Phase 3 moves https://pharmadog.xyz/news/163258 pharmadog en 2026-07-30T11:20:47.000Z Arvinas CEO outlines strategy to rebuild pipeline after lead asset departure https://pharmadog.xyz/news/163233 pharmadog en 2026-07-30T11:12:42.000Z GSK to invest up to $110 million in expanded AI drug-discovery partnership with Relation Therapeutics https://pharmadog.xyz/news/164125 pharmadog en 2026-07-30T10:39:00.000Z BMS CEO says firm not pressured to pursue acquisitions despite quiet M&A year https://pharmadog.xyz/news/162981 pharmadog en 2026-07-30T10:00:00.000Z FDA advisory panel reviews Replimune's experimental melanoma therapy RP1 https://pharmadog.xyz/news/163761 pharmadog en 2026-07-30T09:43:00.000Z Bristol Myers pushes Cobenfy Alzheimer’s psychosis readout to early 2027 after enrollment delays https://pharmadog.xyz/news/162789 pharmadog en 2026-07-30T09:35:05.000Z Sanofi books over €1 billion impairment after ending eczema drug and halting two immunology programs https://pharmadog.xyz/news/163635 pharmadog en 2026-07-30T08:58:00.000Z Attovia, Braveheart Bio, and Vogenx aim to raise over $500M through combined IPOs https://pharmadog.xyz/news/162727 pharmadog en 2026-07-30T08:30:00.000Z A decade after WHO recognition, mycetoma is still one of the world’s most neglected diseases https://pharmadog.xyz/news/162725 pharmadog en 2026-07-30T08:30:00.000Z Medicaid work rules spark confusion over medically frail exemption, risking coverage for chronically ill https://pharmadog.xyz/news/162726 pharmadog en 2026-07-30T08:30:00.000Z Experts warn U.S. pharma reliance on China poses national security threat https://pharmadog.xyz/news/163504 pharmadog en 2026-07-30T08:21:00.000Z Labcorp reports Q2 sales of $3.73 billion, lifts full-year revenue outlook despite missing consensus https://pharmadog.xyz/news/163634 pharmadog en 2026-07-30T07:28:00.000Z Takeda drops its second celiac disease candidate, TAK-101, after unimpressive phase 2 results https://pharmadog.xyz/news/162281 pharmadog en 2026-07-30T07:00:00.000Z Four biotech firms secure Series B funding and open new hiring opportunities https://pharmadog.xyz/news/162282 pharmadog en 2026-07-30T07:00:00.000Z Biopharma layoffs in 2026 often marred by impersonal and poorly timed communications https://pharmadog.xyz/news/163632 pharmadog en 2026-07-30T06:36:00.000Z GSK signs up to $110 million AI data partnership with Relation https://pharmadog.xyz/news/162765 pharmadog en 2026-07-30T05:01:00.000Z Sanofi’s new CEO vows deeper review of late-stage pipeline after series of trial failures https://pharmadog.xyz/news/161941 pharmadog en 2026-07-30T04:32:19.000Z Johnson & Johnson prepares $2.58 billion option to acquire Sail Biomedicines, expanding in-vivo CAR-T portfolio https://pharmadog.xyz/news/161798 pharmadog en 2026-07-30T04:17:00.000Z Biogen’s early Phase 2 data supports tau-targeting Alzheimer’s approach https://pharmadog.xyz/news/161709 pharmadog en 2026-07-30T04:05:00.000Z Red Bull-funded studies downplay risks of mixing energy drinks with alcohol, shaping policy despite independent warnings https://pharmadog.xyz/news/163741 pharmadog en 2026-07-30T04:00:00.000Z Argon Medical issues correction for convenience kits containing lidocaine ampules after FDA safety alert https://pharmadog.xyz/news/163633 pharmadog en 2026-07-30T03:55:00.000Z Boston Scientific lowers full-year revenue outlook as restructuring plan targets slowing growth https://pharmadog.xyz/news/162764 pharmadog en 2026-07-30T03:19:00.000Z J&J invests $785M in Sail Biomedicines, secures option to buy for $2.58B https://pharmadog.xyz/news/166681 pharmadog en 2026-07-30T00:00:00.000Z FDA releases updated guidances for injectable peptide drugs and announces FY 2027 user fee rates https://pharmadog.xyz/news/166679 pharmadog en 2026-07-30T00:00:00.000Z FDA releases FY 2027 user fee rates and updates guidance for injectable peptide ANDAs https://pharmadog.xyz/news/166682 pharmadog en 2026-07-30T00:00:00.000Z EFPIA urges EU lawmakers to further cut clinical trial approval timelines under Biotech Act https://pharmadog.xyz/news/166680 pharmadog en 2026-07-30T00:00:00.000Z Study Finds Accelerated Approval Rarely Used for Adult Cancer Drugs Over Past 20 Years https://pharmadog.xyz/news/166683 pharmadog en 2026-07-30T00:00:00.000Z FDA releases FY 2027 user fee rates for prescription, generic, biosimilar, device and over the counter programs https://pharmadog.xyz/news/164410 pharmadog en 2026-07-29T22:43:56.000Z FDA advisory panel votes 9-3 against approval of Capricor’s Duchenne muscular dystrophy therapy deramiocel https://pharmadog.xyz/news/160693 pharmadog en 2026-07-29T22:43:56.000Z FDA advisory panel votes 9-3 against Capricor's Duchenne therapy deramiocel https://pharmadog.xyz/news/160280 pharmadog en 2026-07-29T21:36:13.000Z NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientists https://pharmadog.xyz/news/160477 pharmadog en 2026-07-29T21:31:00.000Z FDA advisory panel rejects Capricor's Duchenne heart-cell therapy deramiocel https://pharmadog.xyz/news/160201 pharmadog en 2026-07-29T21:22:00.000Z MapLight Therapeutics' mid-stage schizophrenia trial shows modest improvement but shares plunge two-thirds https://pharmadog.xyz/news/160181 pharmadog en 2026-07-29T21:00:00.000Z Latigo's mid-stage trial shows non-opioid pill LTG-001 cuts post-surgery pain, outperforms placebo https://pharmadog.xyz/news/159841 pharmadog en 2026-07-29T19:48:29.000Z FTC sues Hims & Hers over alleged health data sharing and deceptive billing practices https://pharmadog.xyz/news/159704 pharmadog en 2026-07-29T19:14:46.000Z US releases $600M pledged to global vaccine alliance Gavi after year‑long delay